MX2017005373A - Soporte de biomaterial para la regeneracion de mucosa oral. - Google Patents

Soporte de biomaterial para la regeneracion de mucosa oral.

Info

Publication number
MX2017005373A
MX2017005373A MX2017005373A MX2017005373A MX2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A
Authority
MX
Mexico
Prior art keywords
biomaterial scaffold
hydrogel
oral mucosa
regenerating
subjecting
Prior art date
Application number
MX2017005373A
Other languages
English (en)
Inventor
Baiget Orts Amparo
Castro Feo Begoña
Original Assignee
Histocell Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histocell Sl filed Critical Histocell Sl
Publication of MX2017005373A publication Critical patent/MX2017005373A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un procedimiento para preparar una estructura de biomaterial comprendiendo dicho método, (a) proporcionar un hidrogel que comprende una red de fibrina y una red de polisacárido, (b) someter el hidrogel de la etapa a) a un procedimiento de congelación-descongelación para reticular físicamente el hidrogel; y (c) someter el hidrogel reticulado físicamente obtenido tras realizar la etapa b), a una liofilización. La invención también se refiere a la estructura de biomaterial que puede obtenerse mediante el procedimiento tal como se definió anteriormente, así como a dicha estructura de biomaterial para su uso para aumentar, reestablecer o reemplazar parcial o completamente la actividad funcional de una mucosa oral enferma o dañada.
MX2017005373A 2014-10-24 2015-10-23 Soporte de biomaterial para la regeneracion de mucosa oral. MX2017005373A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382417.5A EP3011981A1 (en) 2014-10-24 2014-10-24 A biomaterial scaffold for regenerating the oral mucosa
PCT/EP2015/074610 WO2016062862A1 (en) 2014-10-24 2015-10-23 A biomaterial scaffold for regenerating the oral mucosa

Publications (1)

Publication Number Publication Date
MX2017005373A true MX2017005373A (es) 2017-07-28

Family

ID=51844651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005373A MX2017005373A (es) 2014-10-24 2015-10-23 Soporte de biomaterial para la regeneracion de mucosa oral.

Country Status (11)

Country Link
US (1) US11241516B2 (es)
EP (2) EP3011981A1 (es)
JP (1) JP6633628B2 (es)
KR (1) KR102489773B1 (es)
CN (1) CN107073170B (es)
AU (1) AU2015334897B2 (es)
BR (1) BR112017008117B1 (es)
CA (1) CA2964501C (es)
ES (1) ES2774792T3 (es)
MX (1) MX2017005373A (es)
WO (1) WO2016062862A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020501543A (ja) * 2016-12-07 2020-01-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 網膜色素上皮移植のためのフィブリン支持体を用いた方法及び材料
EP3746092A4 (en) 2018-02-01 2021-10-27 North Carolina State University ANTIMICROBIAL PLATELET-TYPE PARTICLES
CN110760076B (zh) * 2019-11-06 2022-04-08 大连理工大学 一种基于胶体颗粒-iPRF双网络结构的可注射、高强度复合水凝胶及其制备方法和应用
CN110743038B (zh) * 2019-11-06 2021-09-10 大连理工大学 一种双网络结构复合水凝胶及其制备方法和应用
WO2021108791A1 (en) * 2019-11-29 2021-06-03 North Carolina State University Neonatal fibrin scaffolds for promoting wound healing
CN110982125B (zh) * 2019-12-19 2022-01-21 武汉纺织大学 一种形状自恢复多孔复合凝胶及其制备方法与应用
CN113318275B (zh) * 2021-08-03 2021-11-02 首都医科大学附属北京口腔医院 用于牙髓牙本质再生的可降解水凝胶
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114146223A (zh) * 2021-12-10 2022-03-08 三亚悦美科技有限公司 一种重组胶原蛋白复合注射剂及其制备方法
EP4241798A1 (en) * 2022-03-11 2023-09-13 Universidad de Granada Hydrogel suitable to produce artificial tissues

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438198A (en) * 1981-09-30 1984-03-20 Trimedyne, Inc. Biochemically active matrix for use in a bio-artificial organ
AU673659B2 (en) 1991-11-25 1996-11-21 Institute Of Molecular Biology, Inc. Medicament for promoting growth of mammalian nerve
WO2000006724A1 (fr) 1998-07-31 2000-02-10 Kirin Beer Kabushiki Kaisha Medicaments permettant de soigner la neuropathie contenant de la galectine-1 ou ses derives comme substance active
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
JP2010520766A (ja) * 2007-03-09 2010-06-17 コーニング インコーポレイテッド 細胞培養用三次元ガムマトリックス、製造方法および使用方法
TR201809713T4 (tr) * 2009-08-25 2018-07-23 Servicio Andaluz De Salud Agaroz-fibrin biyomalzemelerini kullanarak doku mühendisliğiyle yapay doku üretimi.
KR20110023399A (ko) * 2009-08-31 2011-03-08 한국과학기술연구원 지혈효과 및 기계적 물성이 우수한 지능형 피브린 생체접착제
EP2575909B1 (en) * 2010-06-03 2020-01-15 Technology Innovation Momentum Fund (Israel) Limited Partnership Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
EP2594295A1 (en) 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nerve implants based on a compacted biomaterial containing cells
CN102688525B (zh) * 2012-05-07 2013-11-27 东南大学 一种生物大分子水凝胶及其制备方法
CN103908693B (zh) * 2014-04-15 2015-10-28 山东颐诺生物科技有限公司 一种仿生型海藻酸基复合抗菌敷料及其制备方法

Also Published As

Publication number Publication date
JP6633628B2 (ja) 2020-01-22
US20170340771A1 (en) 2017-11-30
CN107073170B (zh) 2021-06-29
WO2016062862A1 (en) 2016-04-28
BR112017008117B1 (pt) 2020-12-08
AU2015334897B2 (en) 2019-08-01
EP3011981A1 (en) 2016-04-27
KR20170073673A (ko) 2017-06-28
CN107073170A (zh) 2017-08-18
BR112017008117A2 (pt) 2018-02-20
US11241516B2 (en) 2022-02-08
KR102489773B1 (ko) 2023-01-17
AU2015334897A1 (en) 2017-05-18
ES2774792T3 (es) 2020-07-22
EP3209341B1 (en) 2020-01-01
CA2964501A1 (en) 2016-04-28
CA2964501C (en) 2023-05-16
EP3209341A1 (en) 2017-08-30
JP2017531533A (ja) 2017-10-26

Similar Documents

Publication Publication Date Title
MX2017005373A (es) Soporte de biomaterial para la regeneracion de mucosa oral.
EP4219724A3 (en) Compositions and methods for treating non-age-associated hearing impairment in a human subject
BR112018011474A2 (pt) composição, e, método para tratar um sujeito que sofre de uma doença de armazenamento lisossômico.
EP3240551A4 (en) Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
NZ731789A (en) Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
PH12017502283A1 (en) A method of treatment
EP3614301A4 (en) ARTIFICIAL INTELLIGENCE BASED INTERFERENCE DETECTION PROCESS FOR AN ELECTROCARDIOGRAM
MX2021006734A (es) Metodo para tratar el cancer.
MX2018002906A (es) Metodos de tratamiento de trastornos del desarrollo con pipradrol.
BR112017005997A2 (pt) método
WO2014144932A3 (en) Methods of using zscan4 for rejuvenating human cells
EP3183241A4 (en) Catalyst and process for producing 2,5-furandicarboxylic acid from hydromethylfurfural in water
EP3838034A4 (en) SYSTEM, PROCESS AND PROGRAM FOR FLAVOR GENERATION
EP3342858A4 (en) ROR1-POSITIVE MESENCHYMAL STEM CELLS AND PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREOF, AND METHOD FOR PREVENTING OR TREATING DISEASES USING SAID ROR1 POSITIVE MESENCHYMAL STEM CELLS
MX2016016756A (es) Terapia con células madre en patologías endometriales.
PH12016501812A1 (en) Modified sulfamidase and production thereof
SG11201704321TA (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
WO2016168214A3 (en) Immunogenic fusion proteins for the treatment of cancer
EP3677684A4 (en) METHOD OF PREPARING A FULVIC ACID SOLUTION AND FULVIC ACID SOLUTION
EP3689901A4 (en) PROCESS FOR THE PRODUCTION OF VITRIGEL OF COLLAGEN, PROCESS FOR THE PRODUCTION OF VITRIGEL OF PURIFIED COLLAGEN AND VITRIGEL OF COLLAGEN AND VITRIGEL OF PURIFIED COLLAGEN PRODUCED BY THE SAID PROCESSES
EP3484286A4 (en) CROSS-CIRCULATION PLATFORM FOR THE RECOVERY, REGENERATION AND MAINTENANCE OF EXTRACORPAL ORGANS
NZ764440A (en) Use of cell membrane-bound signaling factors
EP3723875A4 (en) TISSUE REGENERATION APPARATUS, SYSTEM AND METHOD
EP4295903A3 (en) Compositions and methods for treating farber disease